AI assistant
Marksans Pharma Ltd. — Capital/Financing Update 2022
May 30, 2022
62142_rns_2022-05-30_7275119d-3cab-47ed-93fe-69d8ca994d44.pdf
Capital/Financing Update
Open in viewerOpens in your device viewer
·t· Marksans Pharma Ltd.
Date: 30[th] May, 2022
BSE Limited
National Stock Exchange of India Limited
Corporate Relation Department Listing Department Phiroze Jeejeeboi Towers, Exchange Plaza, C-l, Block-G, Dalal Street, Bandra-Kurla Complex, Mumbai - 400001. Bandra (East), Mumbai - 400051. Scrip Code: 524404 Symbol: MARKSANS
Sub: Statement on Deviation or Variation of funds raised through Preferential Issue of Convertible Warrants.
Pursuant to Regulation 32 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015 read with SEBI Circular No. CIRlCFD/CMDl1162/20 19 dated December 24, 2019, we hereby confirm that there is no deviation or variation in the use of funds raised through Preferential Issue of Convertible Warrants from the objects stated in the Explanatory Statement to the Notice of Extra-Ordinary General Meeting of the Company dated 15th June, 2021.
Accordingly, a Nil Statement of Deviation, duly reviewed by the Audit Committee of the Company, for the Quarter ended 31 st March, 2022 is given in "Annexure A".
Yours faithfully, For Marksans Pharma Limited
Harshavardhan Panigrahi Company Secretary
Marksans Pharma Ltd
11th, Floor, "GRANDEUR", Opp. Gundecha Symphony, Veera Desai Extension Road, Oshiwara, Andheri 0N), Mumbai - 400 053 • Tel. : +91 224001 2000 • Email: [email protected] www.marksanspharma.com
| Statementof Deviation / Variationin utilisationoffundsraised |
|---|
| Name of listed entityMarksans Pharma Limited |
| Mode of Fund RaisingPreferential Issue |
| Date of Raising Funds20.07.2021 |
| Amount RaisedRs. 93,09,99,994 |
| Report filed for quarterended31slMarch, 2022 |
| MonitoringAgencyNot Applicable |
| MonitoringAgency Name, if applicableNot Applicable |
| Is there a Deviation / Variationin use of funds raisedNo |
| If yes, whetherthe same is pursuantto change in termsNot Applicableof a contractor objects, which was approvedby theshareholders |
| If Yes, Date of shareholderApprovalNot ApplicableExplanationfor the Deviation / VariationNot ApplicableCommentsof the Audit Committeeafter reviewNil |
| Commentsoftheauditors,if anyNil |
Objects for which funds have been raised and where there has been a deviation, in the following table
| table | ||||||
|---|---|---|---|---|---|---|
| Original Object | ModifiedObject, ifany | OriginalAllocation | Modifiedallocation, ifany | Fundsutilised till31th March,2022 |
Amount ofdeviation/variation forthe quarteraccordingtoapplicableobject | Remarksifany |
| Theproceedsofthepreferentialissue are proposedtobeusedtostrengthenthecapitalbaseandtoenhancelongtermfinancialresourcesoftheCompany in orderto fund expansionprogram of theCompany. | None | Rs.93,09,99,994 | None | - | - | Nodeviations |
Deviation or variation could mean:
- (a) Deviation in the objects or purposes for which the funds have been raised or (b) Deviation in the amount offunds actually utilized as against what was originally disclosed or (c) Change in terms of a contract referred to in the fund raising document i.e. prospectus, letter of offer, etc
For Marksans Pharma Limited
==> picture [90 x 28] intentionally omitted <==
----- Start of picture text ----- j(JJJAJ£----- End of picture text -----